ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,055,912 | -64.6% | 36,817 | -70.4% | 0.01% | -61.1% |
| Q1 2023 | $2,981,437 | +220.4% | 124,382 | +126.7% | 0.02% | +260.0% |
| Q4 2022 | $930,510 | +48.6% | 54,865 | +38.0% | 0.01% | +25.0% |
| Q2 2022 | $626,000 | +344.0% | 39,749 | +659.3% | 0.00% | +300.0% |
| Q1 2022 | $141,000 | -81.2% | 5,235 | -66.6% | 0.00% | -88.9% |
| Q3 2021 | $749,000 | +144.8% | 15,684 | +73.5% | 0.01% | +200.0% |
| Q2 2021 | $306,000 | -74.5% | 9,038 | -68.9% | 0.00% | -80.0% |
| Q1 2021 | $1,201,000 | +181.3% | 29,080 | +191.9% | 0.02% | +150.0% |
| Q3 2020 | $427,000 | -71.1% | 9,962 | -68.5% | 0.01% | -76.9% |
| Q2 2020 | $1,477,000 | – | 31,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
| Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
| ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
| FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
| MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
| Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
| Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
| Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
| New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |